Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • IBseq
    Member
    • Jul 2012
    • 56

    #16
    Hi Artur,
    yes, that makes sense. Thus I shall not take in consideration the p/q values and their consequent significance.

    I did follow the tophat/cufflinks/cuffcompare/cuffdiff pipeline, but I had a doubt and ran it twice with a difference. I shall outline that I have one control sample and 7 treated samples but I am not using them as replicates, thus I ran them separately each of them against the control.

    1st run: tophat.cufflinks with refence annotation; then cuffcompare with the cufflinks of all 7 samples and control sample plus reference annotation. I used this output of couffcompare as input for 7 cuffdiffs (one for each of the 7 treated samples).

    2nd run: tophat/cufflinks with reference annotation, then cuffcompare with cufflinks of each of the treated samples with reference annotation (thus I have 7 cuffcompare outputs). I used one by one each of these cuffcompare outputs to run 7 cuffdiffs.

    My question: I have more consistent results when I run a cuffcompare which includes all my cufflinks (control + 7 treated) rather than cifflink control+cufflink treated one by one. Similarly, I do have more interesting results if I run 7 different cuffdiff rather thn one cuffdiff by taking my 7 treated samples as replicates (these 7 samples are 7 people biopsis of the same tumor)

    which way is best? I can use the first run and take it as reliable?

    sorry for long question...Hope you can help.

    thanks,
    ib

    Comment

    • tankman
      Member
      • Sep 2012
      • 22

      #17
      interpretation of FPKM tracking files at gene level

      hi guys,

      quick question for you cuffdiff-output experts:

      I'm having trouble understanding why the gene level fpkm tracking file shouldn't be unique in the gene short name. That's what I thought the description entailed (sums over isoforms to get gene level FPKM matrix) from the cufflinks website:

      genes.fpkm_tracking Gene FPKMs. Tracks the summed FPKM of transcripts sharing each gene_id


      Instead, e.g., I get

      users-mac-pro:cuffdiff_SE_plus_PE_trimmed_all_samples user$ grep ADAR genes.fpkm_tracking | cut -f 1-6
      XLOC_000826 - - XLOC_000826 ADAR TSS1470
      XLOC_002045 - - XLOC_002045 ADAR TSS3725,TSS3726,TSS3727,TSS3728
      XLOC_003087 - - XLOC_003087 ADARB2 TSS5153
      XLOC_003599 - - XLOC_003599 ADARB2 TSS6095,TSS6096,TSS6097,TSS6098
      XLOC_019202 - - XLOC_019202 ADARB1 TSS32453,TSS32454,TSS32455
      XLOC_019369 - - XLOC_019369 ADARB1 TSS32746


      All the TSS id's correspond to the same physical locus. I am misunderstanding why gene short id is different than gene id. Can you please help me interpret this data?

      thanks,
      tankman

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        Yesterday, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM
      • GATTACAT
        Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
        by GATTACAT
        Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
        07-01-2026, 11:43 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:04 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...